Support studies that employ data-driven approaches to robustly test the efficacy of multi-modal interventions that combine pharmacological and lifestyle interventions.
Initiate clinical trials for at least 3 interventions combining pharmacological and non-pharmacological interventions for AD and ADRD treatment or prevention. These trials should incorporate digital health devices and deep, longitudinal molecular phenotyping to:
track person-specific trajectories of treatment response.
understand the therapeutic mechanism of action.
enable comprehensive success/failure analysis.
Ensure inclusion of diverse populations in studies.
Summary of Key Accomplishments
This milestone has yet to be initiated. Accomplishments are forthcoming.
This information is current as of March 2022.
- Research Implementation Area
- Non-Pharmacological Interventions
- To Be Initiated